Nicholas Investment Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-312,824
Closed -$6.12M 218
2021
Q3
$6.12M Sell
312,824
-145,552
-32% -$5.54M 0.45% 84
2021
Q2
$20.5M Buy
458,376
+125,042
+38% +$5.8M 1.29% 20
2021
Q1
$16.7M Buy
333,334
+155,610
+88% +$10.6M 1.17% 30
2020
Q4
$15.9M Buy
177,724
+135,440
+320% +$11.4M 1.23% 25
2020
Q3
$3.23M Buy
+42,284
New +$2.69M 0.35% 82

Other funds holding CELL

Nicholas Investment Partners's CELL Position: Q4 2021 in Review

Nicholas Investment Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 312,824 shares — an estimated $6.12M sold.

Nicholas Investment Partners first reported a position in CELL in Q3 2020 and held it in 5 quarters. The position peaked at $20.5M in Q2 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

  • Nicholas Investment Partners reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Nicholas Investment Partners sold 312,824 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $6.12M.
  • Nicholas Investment Partners first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Nicholas Investment Partners's PhenomeX Inc. Common Stock position peaked at $20.5M in Q2 2021.
  • 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on Nicholas Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.